Correction: Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?".
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Works matching IS 0937941X AND DT 2024 AND VI 35 AND IP 11
Results: 21
1
2
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 2061, doi. 10.1007/s00198-024-07243-w
- By:
- Publication type:
- Article
3
Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 2025, doi. 10.1007/s00198-024-07240-z
- By:
- Publication type:
- Article
4
Clinical features of fallers and non-fallers: finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older adults with and without osteoporosis.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 2007, doi. 10.1007/s00198-024-07233-y
- By:
- Publication type:
- Article
5
Investigating the relationship between sagittal spinal curvature and fall incidence and fall risk among elderly nursing home residents.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1999, doi. 10.1007/s00198-024-07232-z
- By:
- Publication type:
- Article
6
Sarcopenia definitions and their association with injurious falls in older Swedish women from the Sahlgrenska University Hospital Prospective Evaluation of Risk of Bone fractures (SUPERB) study.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1963, doi. 10.1007/s00198-024-07196-0
- By:
- Publication type:
- Article
7
Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1973, doi. 10.1007/s00198-024-07225-y
- By:
- Publication type:
- Article
8
Fracture risk assessment in the presence of competing risk of death.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1989, doi. 10.1007/s00198-024-07224-z
- By:
- Publication type:
- Article
9
Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1943, doi. 10.1007/s00198-024-07211-4
- By:
- Publication type:
- Article
10
Prevalence of low vitamin D levels among older US Asian and Pacific Islander adults.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 2017, doi. 10.1007/s00198-024-07197-z
- By:
- Publication type:
- Article
11
Insulin resistance, bone health, and fracture risk.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1909, doi. 10.1007/s00198-024-07227-w
- By:
- Publication type:
- Article
12
Risk factors associated with 1-year mortality after osteoporotic hip fracture in Hawaiʻi: higher mortality risk among Native Hawaiians and other Pacific Islanders.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1931, doi. 10.1007/s00198-024-07195-1
- By:
- Publication type:
- Article
13
Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?".
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
14
The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1881, doi. 10.1007/s00198-024-07190-6
- By:
- Publication type:
- Article
15
The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1897, doi. 10.1007/s00198-024-07191-5
- By:
- Publication type:
- Article
16
Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 2055, doi. 10.1007/s00198-024-07095-4
- By:
- Publication type:
- Article
17
Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
18
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1919, doi. 10.1007/s00198-024-07161-x
- By:
- Publication type:
- Article
19
Educational gradient in hip fracture incidence in Norway. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 2047, doi. 10.1007/s00198-024-07133-1
- By:
- Publication type:
- Article
20
The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 2037, doi. 10.1007/s00198-024-07180-8
- By:
- Publication type:
- Article
21
Clinical characteristics and surgical outcomes of vertebral lesions associated with tumor-induced osteomalacia: report of 16 patients and review of the literature.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 11, p. 1951, doi. 10.1007/s00198-024-07178-2
- By:
- Publication type:
- Article